| 词条 | Conceptus Inc. |
| 释义 |
Founded in 1992, the corporation is headquartered in Mountain View, California. The company began development of micro-catheter and guidewire systems that allowed physicians to access and navigate the fallopian tubes using a non-incisional approach. While this technology was first used in products to diagnose or treat infertility, in 1998 the company focused on the design, development, and clinical testing of Essure, a non-incisional alternative to tubal ligation.[1] Essure showed promise by eliminating the cutting, clipping, and burning associated with tubal ligation. After clinical testing, Conceptus began marketing Essure commercially in Australia, Singapore, Europe, and Canada. In 2002 the US Food and Drug Administration approved the use of Essure in the United States.[1] On April 29, 2013, Bayer AG made a cash offer of $31.00 for Conceptus, a 20% premium to the company's stock market price, valuing it at $1.1bn.[2] The deal completed and closed on June 5, 2013.[3] References1. ^{{cite web|url=https://www.accessdata.fda.gov/cdrh_docs/pdf2/P020014b.pdf|title=Summary of Safety and Effectiveness Data|publisher=U.S. Food and Drug Administration|accessdate=February 23, 2018}} 2. ^1 {{cite web|url=https://www.bbc.co.uk/news/business-22336625|title=Bayer to buy contraceptive firm Conceptus|publisher=BBC News|date=April 29, 2013|accessdate=June 24, 2014}} 3. ^1 2 {{cite web|url=http://www.fda.gov/medicaldevices/productsandmedicalprocedures/implantsandprosthetics/ucm371014.htm|title=Essure Permanent Birth Control|publisher=U.S. Food and Drug Administration|accessdate=June 24, 2014}} External links
5 : Bayer brands|Companies established in 1992|Health care companies based in California|Companies based in Mountain View, California|Companies formerly listed on NASDAQ |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。